A new study on circulating tumor DNA (ctDNA) testing for advanced breast cancer has unveiled encouraging results, with high ...

But she was diagnosed again at the age of 38 and was given about a year to live.It wasn’t until that second diagnosis that ...

A new study on circulating tumor DNA (ctDNA) testing for advanced breast cancer has unveiled encouraging results, with high ...

Several studies have been completed looking at the effect of BPO in women at high risk of developing ovarian cancer because of family history or because of being mutation carriers of either BRCA1 ...

For years, breast cancer treatment has been guided by genetic alterations found in tumor tissue, typically through invasive biopsies.

More and more studies show that men face risks of cancer from BRCA1 and BRCA2 genetic mutations that are most often associated with breast and ovarian cancers in women. According to a JAMA ...

AI chipmaker Nvidia and research partners have created what they call the largest artificial intelligence system yet for ...

Genetics significantly impact cancer risk, particularly in inherited mutations like BRCA1/BRCA2, which increase susceptibility to breast and ovarian c ...